DaVita (DVA) Gains Controlling Interest in Kidney Care Company NephroLife
Down)
DaVita Inc. (NYSE: DVA), has acquired controlling interest in NephroLife, a leading Bangalore-based kidney care company.
DaVita had previously announced making a minority investment in the company. Specific terms of the deal were not disclosed.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
DaVita had previously announced making a minority investment in the company. Specific terms of the deal were not disclosed.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: SAP's (SAP) America Unit to Buy Ariba (ARBA) for $45/Share
- BofA (BAC), Barclays (BCS) to Sell Remaining Archstone Interest in $1.58B Deal to Lehman Bros.
- Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
